Sarah Cooper, Minister Counsellor and Director for Climate, Development, Science and Technology on the British High Commission.
New Delhi
A Scottish musical is utilizing the facility of storytelling and dwell efficiency to warn of the general public well being threat from antimicrobial resistance (AMR), the British High Commission introduced on Sunday.
The British High Commission hosted the India premiere of Lifeline, with a multi-city tour of the complete manufacturing earmarked in India for 2027.
AMR arises when medicines cease working in opposition to infections, posing a severe and rising risk to public well being worldwide.
Organised on the British Council in New Delhi, the premiere of the 60-minute efficiency by West End and Broadway artists introduced collectively senior figures from the Indian Government, philanthropy, business, academia, and the healthcare sector, in accordance to the British High Commission.
Sarah Cooper, Minister Counsellor and Director for Climate, Development, Science and Technology, British High Commission, stated, “Drug-resistant infections pose a severe and rising risk to folks in each our international locations and internationally. The UK and India have been working shoulder to shoulder on this problem for years, investing in analysis, strengthening laboratories, growing new diagnostics, and constructing the proof base we’d like to act.
“This fantastic musical really shows that tackling this issue is not just a matter for scientists and policymakers, it is a conversation that belongs to all of us. By bringing the world-class performance to New Delhi, we are taking that message to new audiences in a way that is bold, creative, and genuinely moving. I am proud of the partnership we have built, and I look forward to seeing it grow.”
Technology and innovation, together with healthcare, is a precedence underneath UK-India Vision 2035.
Under this flagship tech partnership, the British High Commission famous that AMR sits on the coronary heart of our shared dedication to pandemic preparedness and our joint work on vaccines, recognising that tackling drug-resistant infections is important to defending each our populations from future well being threats.
UK-India collaboration to sort out AMR spans analysis, innovation, diagnostics, laboratory strengthening, and surveillance throughout human well being, animals, and the surroundings.
The British High Commission highlighted that this contains over 10 million kilos sterling invested by UK Research and Innovation via a number of analysis programmes, in addition to the Fleming Fund, which has invested round 600,000 kilos sterling in laboratory strengthening and surveillance in India.
READ MORE: Farkhanda Khan Fida’s artistic journey is inspired by M FHusain
An additional 4.8 million kilos sterling partnership between the UK’s Global Innovation Fund for drug resistance and Bengaluru’s Centre for Cellular and Molecular Platforms focuses particularly on environmental threats, supporting improvements reminiscent of new instruments to take away antibiotic residues from wastewater and cutting-edge moveable units for monitoring resistance within the discipline.